Advertisement
Advertisement

ARWR

ARWR logo

Arrowhead Research Corporation

70.19
USD
Sponsored
-5.01
-6.66%
Jun 02, 10:09 UTC -4
Open

ARWR Earnings Reports

Positive Surprise Ratio

ARWR beat 13 of 41 last estimates.

32%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$56.00M
/
-$1.30
Implied change from Q2 26 (Revenue/ EPS)
-24.06%
/
+39.78%
Implied change from Q3 25 (Revenue/ EPS)
+101.67%
/
+3.17%

Arrowhead Research Corporation earnings per share and revenue

On May 07, 2026, ARWR reported earnings of -0.93 USD per share (EPS) for Q2 26, beating the estimate of -1.21 USD, resulting in a 23.20% surprise. Revenue reached 73.74 million, compared to an expected 81.59 million, with a -9.63% difference. The market reacted with a -6.75% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of -1.30 USD, with revenue projected to reach 56.00 million USD, implying an increase of 39.78% EPS, and decrease of -24.06% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Belite Bio, Inc - ADR
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.64
Actual
-$0.68
Surprise
-4.87%
logo
Immunovant, Inc. Common Stock
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.61
Actual
-$0.73
Surprise
-19.11%
logo
Roivant Sciences Ltd. Common Shares
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.35
Actual
-$0.57
Surprise
-64.63%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
logo
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
logo
Scilex Holding Company Common Stock
Report Date
May 20, 2026 For Q1 26
Estimate
-
Actual
-$4.76
Surprise
-
logo
Akari Therapeutics plc ADR (0.01 USD)
Report Date
May 19, 2026 For Q1 26
Estimate
-$1.40
Actual
-$1.57
Surprise
-11.81%
logo
EVOGENE LTD.
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.60
Surprise
-117.86%
FAQ
For Q2 2026, Arrowhead Research Corporation reported EPS of -$0.93, beating estimates by 23.2%, and revenue of $73.74M, -9.63% below expectations.
The stock price moved down -6.75%, changed from $77.95 before the earnings release to $72.69 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 13 analysts, Arrowhead Research Corporation is expected to report EPS of -$1.30 and revenue of $56.00M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement